<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC8147512/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Characteristics of the dataset</p>
 </caption>
 <thead>
  <tr>
   <th align="left" rowspan="2" colspan="1" id="0-0-B-a">Subset</th>
   <th align="left" rowspan="2" colspan="1" id="0-1-B-a">N</th>
   <th align="left" colspan="2" rowspan="1" id="0-2-b">N: Sex (%)</th>
   <th align="left" colspan="3" rowspan="1" id="0-4-c">N: APOE ε4 dose (%)</th>
   <th align="left" rowspan="2" colspan="1" id="0-7-B-a">Mean age at death (sd)</th>
   <th align="left" rowspan="2" colspan="1" id="0-8-B-a">Mean CAA (sd)</th>
   <th align="left" colspan="4" rowspan="1" id="0-9-d">N: Thal (%)</th>
   <th align="left" colspan="3" rowspan="1" id="0-13-c">N: Braak stage (%)</th>
  </tr>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="1-2-.">Male</th>
   <th align="left" colspan="1" rowspan="1" id="1-3-.">Female</th>
   <th align="left" colspan="1" rowspan="1" id="1-4-.">0</th>
   <th align="left" colspan="1" rowspan="1" id="1-5-.">1</th>
   <th align="left" colspan="1" rowspan="1" id="1-6-.">2</th>
   <th align="left" colspan="1" rowspan="1" id="1-9-.">2</th>
   <th align="left" colspan="1" rowspan="1" id="1-10-.">3</th>
   <th align="left" colspan="1" rowspan="1" id="1-11-.">4</th>
   <th align="left" colspan="1" rowspan="1" id="1-12-.">5</th>
   <th align="left" colspan="1" rowspan="1" id="1-13-.">4</th>
   <th align="left" colspan="1" rowspan="1" id="1-14-.">5</th>
   <th align="left" colspan="1" rowspan="1" id="1-15-.">6</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left">All</td>
   <td align="left">821</td>
   <td align="left">370 (45%)</td>
   <td align="left">451 (55%)</td>
   <td align="left">287 (35%)</td>
   <td align="left">414 (50%)</td>
   <td align="left">120 (15%)</td>
   <td align="left">80.1 (8.6)</td>
   <td align="left">0.85 (0.76)</td>
   <td align="left">
    <p>3</p>
    <p>(0%)</p>
   </td>
   <td align="left">
    <p>60</p>
    <p>(7%)</p>
   </td>
   <td align="left">
    <p>69</p>
    <p>(8%)</p>
   </td>
   <td align="left">
    <p>689</p>
    <p>(84%)</p>
   </td>
   <td align="left">98 (12%)</td>
   <td align="left">280 (34%)</td>
   <td align="left">443 (54%)</td>
  </tr>
  <tr>
   <td align="left">
    <i>APOE</i>ε4 pos (ε4 +) 
   </td>
   <td align="left">534</td>
   <td align="left">241 (45%)</td>
   <td align="left">293 (55%)</td>
   <td align="left">0 (0%)</td>
   <td align="left">414 (78%)</td>
   <td align="left">120 (22%)</td>
   <td align="left">80.5 (8.2)</td>
   <td align="left">0.96 (0.77)</td>
   <td align="left">
    <p>1</p>
    <p>(0%)</p>
   </td>
   <td align="left">
    <p>33</p>
    <p>(6%)</p>
   </td>
   <td align="left">
    <p>48</p>
    <p>(9%)</p>
   </td>
   <td align="left">
    <p>452</p>
    <p>(85%)</p>
   </td>
   <td align="left">65 (12%)</td>
   <td align="left">165 (31%)</td>
   <td align="left">304 (57%)</td>
  </tr>
  <tr>
   <td align="left">
    <i>APOE</i>ε4 neg (ε4-) 
   </td>
   <td align="left">287</td>
   <td align="left">129 (45%)</td>
   <td align="left">158 (55%)</td>
   <td align="left">287 (100%)</td>
   <td align="left">0 (0%)</td>
   <td align="left">0 (0%)</td>
   <td align="left">79.4 (9.2)</td>
   <td align="left">0.72 (0.70)</td>
   <td align="left">
    <p>2</p>
    <p>(1%)</p>
   </td>
   <td align="left">
    <p>27</p>
    <p>(9%)</p>
   </td>
   <td align="left">
    <p>21</p>
    <p>(7%)</p>
   </td>
   <td align="left">
    <p>237</p>
    <p>(83%)</p>
   </td>
   <td align="left">33 (12%)</td>
   <td align="left">115 (40%)</td>
   <td align="left">139 (48%)</td>
  </tr>
  <tr>
   <td align="left">Males</td>
   <td align="left">370</td>
   <td align="left">370 (100%)</td>
   <td align="left">0 (0%)</td>
   <td align="left">129 (35%)</td>
   <td align="left">180 (49%)</td>
   <td align="left">61 (16%)</td>
   <td align="left">78.4 (8.1)</td>
   <td align="left">0.98 (0.79)</td>
   <td align="left">
    <p>1</p>
    <p>(0%)</p>
   </td>
   <td align="left">
    <p>31</p>
    <p>(8%)</p>
   </td>
   <td align="left">
    <p>33</p>
    <p>(9%)</p>
   </td>
   <td align="left">
    <p>305</p>
    <p>(82%)</p>
   </td>
   <td align="left">53 (14%)</td>
   <td align="left">136 (37%)</td>
   <td align="left">181 (49%)</td>
  </tr>
  <tr>
   <td align="left">Females</td>
   <td align="left">451</td>
   <td align="left">0 (0%)</td>
   <td align="left">451 (100%)</td>
   <td align="left">158 (35%)</td>
   <td align="left">234 (52%)</td>
   <td align="left">59 (13%)</td>
   <td align="left">81.5 (8.7)</td>
   <td align="left">0.79 (0.72)</td>
   <td align="left">
    <p>2</p>
    <p>(0%)</p>
   </td>
   <td align="left">
    <p>29</p>
    <p>(6%)</p>
   </td>
   <td align="left">
    <p>36</p>
    <p>(8%)</p>
   </td>
   <td align="left">
    <p>384</p>
    <p>(85%)</p>
   </td>
   <td align="left">45 (10%)</td>
   <td align="left">144 (32%)</td>
   <td align="left">262 (58%)</td>
  </tr>
 </tbody>
 <tfoot>
  <p>Characteristics are provided for all AD individuals and each of the subsets defined by 
   <i>APOE</i>e4 carrier status ( ±) and Sex (M/F). N = number, SD = standard deviation, Thal “L” refers to the two Thal phase levels defined as low, Thal “H” refers to the two Thal phase levels defined as high in the converted binary trait 
  </p>
 </tfoot>
</table>
